Gene combination for human tumor grading and application of gene combination
A gene combination and tumor grading technology, applied in the field of gene combination of human tumor grading, can solve the problems of unreliable malignancy grading, lack of external verification, inability to apply, etc., achieving excellent objectivity and reliability, and wide universality. , the effect of improving sequencing depth and accuracy
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0081] Embodiment 1 is used for the gene combination (Panel) of human tumor classification
[0082] The present invention mainly uses Peking University First Hospital urothelial carcinoma exome sequencing high-throughput database for screening, and confirms a gene combination (panel) for grading human tumors, the gene combination includes gene set A, gene fragment Set B and gene fragment set C;
[0083] The gene set A includes: ACVR1B, ATP4B, AZGP1, BRAF, BRCA1, BRCA2, CRYZL1, DCTN1, E2F3, EGFR, ERBB2, ERCC2, ESPL1, FGFR3, FKBP6, GZMM, H3-5, IGLL5, IRF7, METTL24, At least one of MORN5, MTOR, NPY1R, PET100, PIK3CA, PPARG, PTPN11, PTX4, RGPD8, SERPINA12, STAG2 and ZNF141;
[0084]所述的基因片段集B包括:chr1:155289001-155911999、chr1:226259001-226736999、chr8:30515001-30892999、chr8:42065001-43147999、chr9:134612001-135906999、chr11:48509001-55112999、chr14:24768001-105145999 , at least one of chr16:1-73083999, chr18:1-319999 and chr18:15325001-19749999; the position of the gene segment in the ...
Embodiment 2
[0106] Example 2 A method for grading the degree of malignancy and predicting prognosis of human urothelial carcinoma
[0107] This embodiment provides a method for detecting the grade of human tumors, including using the gene panel in Embodiment 1 to grade the malignancy of human urothelial carcinoma and predict the prognosis, and the specific steps are as follows:
[0108] (1) Take urothelial carcinoma tissue and healthy control tissue specimens, the urothelial carcinoma tissue specimens can be urothelial carcinoma cell lines, fresh urothelial carcinoma specimens, frozen urothelial carcinoma specimens or paraffin-embedded urine Urothelial carcinoma specimens; healthy control tissues can be tissues from known healthy people, or paracancerous tissues or peripheral blood from urothelial carcinoma patients themselves. In this embodiment, the paraffin-embedded urothelial carcinoma specimens were selected, and the healthy control tissue was normal paracancerous tissue, DNA was ext...
Embodiment 3
[0114] As an alternative embodiment of Example 2, in the present invention, the genes in the gene combination (panel) in Example 1 are allowed to be selected and recombined to form a new gene combination, and the judging criteria are, from the gene set For the genes selected in A, the gene mutation of at least one of them indicates that the urothelial cancer patients are in the low-risk group; for the gene fragments selected from gene fragment set B, the gene copy number of at least one region decrease, indicating that the patients with urothelial carcinoma are in the low-risk group; for the gene fragments selected from the gene fragment set C, at least one region of the gene copy number increases, indicating that the patients with urothelial carcinoma are in the low-risk group On the contrary, there is no gene mutation or copy number variation in the genes selected in gene set A, and at the same time, there is no copy number reduction in the fragments selected in gene fragment...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com